NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells
NKG2A基因变异可预测急性髓系白血病(AML)免疫治疗的疗效,并调节NK细胞的谱系和功能。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2023-007202
Brwa Ali Hussein # ,Linnea Kristenson # ,Silvia Pesce ,Anne Wöhr ,Yarong Tian ,Alexander Hallner ,Mats Brune ,Kristoffer Hellstrand ,Ka-Wei Tang ,Elin Bernson ,Fredrik B Thorén